The global US Autoinjectors Market is projected to expand to a value of US$1.45 billion in 2030 from US$0.65 billion in 2024, with a significant ...

With the global prevalence of obesity on the rise, it is crucial to explore the neural mechanisms linked to obesity and its ...

Packer, M., et al. (2025) Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial. JACC . doi ...

While pharma giants Novo Nordisk and Eli Lilly may have a solid hold on the obesity arena, Rhythm Pharmaceuticals is looking ...

Given that primary care doctors only have an average of 18 minutes allocated to seeing each patient, how is it possible to conduct routine assessment and comprehensive obesity management?

New Delhi [India], March 28: A patient at Sarvodaya Hospital ... non-surgical procedure for severe obesity.

Equally important, what does the future hold for patients with obesity, given that it lacks broad recognition as a chronic disease? “We’ve been dealing with this for centuries — that obesity ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

About half of Americans "strongly" or "somewhat" favor having Medicare and Medicaid cover weight-loss drugs for people who ...

"Stress and its associated pathways can exacerbate disease progression, and we know that obesity fuels certain cancers, potentially impacting a patient’s response to treatment," he said.

Among patients with asthma and obesity, about a quarter of encounters include obesity management, according to a poster at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy ...